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VNSVagus nerve stimulation (VNS) is generally considered as a palliative treatment for patients with drug-
resistant partial-onset epilepsy. We report a case in which a patient with drug-resistant epilepsia partialis
continua (EPC), became seizure-free for 15 months with VNS combined with antiepileptic medication
regimens. To our knowledge, similar cases have not been reported previously.
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Vagus nerve stimulation (VNS) is an effective adjunctive therapy for
patients with drug-resistant partial-onset epilepsy [1]. It decreases sei-
zure frequency by approximately 50% in 30–40% of implanted patients
[2]. The efﬁcacy of VNS has also been demonstrated in treating various
types of generalized epilepsies, including genetic generalized epilepsy
(GGE) and Lennox–Gastaut syndrome [3]. Here,we report that a patient
became seizure-free in epilepsia partialis continua (EPC)with VNS ther-
apy combined with antiepileptic drug (AED) regimens.
2. Case report
A 21-year-old, right-handedman started having seizures at the age of
18. He reported countless limb shaking for about 10 s andoccasional gen-
eralized tonic-clonic seizures at a frequency of 5–7 times per year. His sei-
zures were commonly precipitated by stress, sleep deprivation, AED
noncompliance, and changes in emotion, such as excitation and anger.
He was initially treated with valproic acid (VPA) with minimal beneﬁts.
He was also treated with carbamazepine (CBZ), which provided better
seizure control, but its effectiveness disappeared four months later.
Then, he was treated with lamotrigine (LTG) at 200 mg daily,
levetiracetam (LEV) at 1250 mg daily, and topiramate (TPM) at 200 mgXijing Hospital, Fourth Military
032, China. Tel.: +86 29 8477
.
nc. Open access under CC BY license.dailywithminimal beneﬁts for the last severalmonths. His general phys-
ical and neurological examinations were normal, and his family history
was noncontributory. However, he suffered head trauma at the age of
three, and his brain MRI revealed that the signal of the cortex in the
head of the right putamen disappeared, and the lenticular nucleus was
somewhat small, with suspected developmental delay (Fig. 1), and
long-term video-EEG monitoring revealed small spike-wave discharges.
Sometimes, he could not even say a word or have dinner due to mouth
twitching, which also prevented him from working. He was referred by
his neurologist to our epilepsy center for evaluation for possible VNS
therapy.
A vagus nerve stimulator was subsequently implanted in Sept. 2011.
The initial stimulation parameterswere the following: current output of
0.25 mA, frequency of 30 Hz, pulse width of 250 μs, 30 s of signal-on
time, and 5 min of signal-off time. The patient had two prominent
twitches of the mouth per week. Then, his stimulation current output
was changed to 0.50 mA, and his seizures became countless as they
were pre-operation. Fortunately, he became seizure-free after his stim-
ulation current was reverted to 0.25 mA. After one month of seizure
freedom, the patient withdrew from his LEV and TPM medications. He
has remained seizure-free for almost 9 months, during which time he
has been gainfully employed.
3. Discussion
In this particular patient, a history of AED noncompliance may have
falsely created the appearance of drug-resistant seizures. In general, pa-
tients with VNS rarely achieve seizure freedom [4]. Only one of 198
(0.5%) patients became seizure-free in an early randomized active-
control trial. In more recent uncontrolled case studies, signiﬁcantly
Fig. 1. The signal of the cortex in the head of the right putamen has disappeared, the
lenticular nucleus is somewhat small, and the right frontotemporal lobe and insular
lobe show an abnormal signal, with suspected developmental delay.
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Janszky et al. [5] reported that 6 of 47 (13%) patients became seizure-
free, while Ghaemi et al. [6] reported that 10 of 144 (6.9%) patients be-
came free from seizures. Earlier treatment with VNS in the course of a
seizure disorder is associated with a greater likelihood of improvement
[7]. The patient in this study not only has been seizure-free for
9 months, but was also able to taper off AED treatment VNS implanta-
tion. We believe that his remission was achieved by VNS.
Just as any “electronic medication”, the parameter adjustment of
VNS, like the dosage of medications, is based on patient proﬁles. It is a
double-edged sword in terms of VNS efﬁcacy for drug-resistant epilepsy.When the standard parameters used are 0.25 mA, 20 Hz, 250 μs, 30 s on,
and 5 min off, continuously, the patient experienced two prominent
twitches of the mouth weekly. When the parameters were changed
(0.50 mA, 20 Hz, 250 μs, 30 s on, and 5 min off, continuously), his
seizures became countless as they were pre-operation. When the
parameters were adjusted back to 0.25 mA, 20 Hz, 250 μs, 30 s on, and
5 min off, continuously, the patient became seizure-free.
Neurostimulation is a rapidly developing therapy for drug-resistant
epilepsy. We believe that it is clinically important to document such
cases in the hope of appreciating the clinical features of patients who
have the potential to become seizure-free with VNS therapy combined
with antiepileptic medication regimens, and, for some patients, the
chance to withdraw from the use of AEDs.
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